Nigeria, on Thursday, launched a diagnostic kit, RNASwift, for the identification of coronavirus’ causal agent.
The new diagnostic kit was designed, developed and validated by some Nigerian scientists at the National Biotechnology Development Agency.
NBDA Director General, Prof Alex Akpa, said at the launch in Abuja on Thursday that the kit has huge potential for the country’s plan at scaling up testing for COVID-19.
“The diagnostic kit is a product of cutting-edge biotechnology, which involves the exploitation of molecular biology to design, develop and validate a cost-effective but yet very top-of-the-range kit for COVID-19 testing,” Akpa said.